Teva Urges High Court To Review Disputed Labeling Theory
Teva Pharmaceuticals USA Inc. has urged the U.S. Supreme Court to review the controversial "failure to update" theory in which plaintiffs generally claim that generic-drug makers should be held liable for...To view the full article, register now.
Already a subscriber? Click here to view full article